{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:04:12Z","timestamp":1791335052327,"version":"4.3.1"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council (GB)","doi-asserted-by":"publisher","award":["G1000417\/94909"],"award-info":[{"award-number":["G1000417\/94909"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["090006"],"award-info":[{"award-number":["090006"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research (GB)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00467-015-3241-0","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T15:48:07Z","timestamp":1447170487000},"page":"1383-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The non-immunosuppressive management of childhood nephrotic syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"James","family":"McCaffrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J. A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"3241_CR1","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561\u2013564","DOI":"10.1016\/S0022-3476(81)80760-3"},{"key":"3241_CR2","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1984) Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years\u2019 observation. Report of the International Study of Kidney Disease in Children. Pediatrics 73:497\u2013501","DOI":"10.1542\/peds.73.4.497"},{"key":"3241_CR3","unstructured":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie (1988) Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet 333:380\u2013383"},{"key":"3241_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01956754","volume":"152","author":"JH Ehrich","year":"1993","unstructured":"Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 152:357\u2013361","journal-title":"Eur J Pediatr"},{"key":"3241_CR5","unstructured":"[No authors listed] (1979) Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of \"Arbetsgemeinschaft fur Padiatrische Nephrologie\". Lancet 1:401\u2013403"},{"key":"3241_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769\u2013776","journal-title":"J Am Soc Nephrol"},{"key":"3241_CR7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(70)91905-7","volume":"760","author":"J Churg","year":"1970","unstructured":"Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the international study of kidney disease in children. Lancet 760:1299\u20131302","journal-title":"Lancet"},{"key":"3241_CR8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jpeds.2009.12.020","volume":"156","author":"M Vivarelli","year":"2010","unstructured":"Vivarelli M, Moscaritolo E, Tsalkidis A, Massella L, Emma F (2010) Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome. J Pediatr 156:965\u2013971","journal-title":"J Pediatr"},{"key":"3241_CR9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","volume":"124","author":"DS Gipson","year":"2009","unstructured":"Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747\u2013757","journal-title":"Pediatrics"},{"key":"3241_CR10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","volume":"1","author":"RS Trompeter","year":"1985","unstructured":"Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS (1985) Long-term outcome for children with minimal-change nephrotic syndrome. Lancet 1:368\u2013370","journal-title":"Lancet"},{"key":"3241_CR11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","volume":"147","author":"EM Ruth","year":"2005","unstructured":"Ruth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ (2005) Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 147:202\u2013207","journal-title":"J Pediatr"},{"key":"3241_CR12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550\u2013557","journal-title":"Am J Kidney Dis"},{"key":"3241_CR13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00467-012-2239-0","volume":"28","author":"MA Saleem","year":"2013","unstructured":"Saleem MA (2013) New developments in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28:699\u2013709","journal-title":"Pediatr Nephrol"},{"key":"3241_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM, Kidney Disease: Improving Global O (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"3241_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00467-006-0264-6","volume":"22","author":"AS Abeyagunawardena","year":"2007","unstructured":"Abeyagunawardena AS, Sebire NJ, Risdon RA, Dillon MJ, Rees L, Van\u2019t Hoff W, Kumarasiri PV, Trompeter RS (2007) Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 22:215\u2013221","journal-title":"Pediatr Nephrol"},{"key":"3241_CR16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2215\/CJN.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Ozkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Ozcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F (2015) Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol 10:592\u2013600","journal-title":"Clin J Am Soc Nephrol"},{"key":"3241_CR17","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1542\/peds.2006-2164","volume":"119","author":"BG Hinkes","year":"2007","unstructured":"Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907\u2013e919","journal-title":"Pediatrics"},{"key":"3241_CR18","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ejhg.2014.252","volume":"23","author":"G Bullich","year":"2015","unstructured":"Bullich G, Trujillano D, Santin S, Ossowski S, Mendizabal S, Fraga G, Madrid A, Ariceta G, Ballarin J, Torra R, Estivill X, Ars E (2015) Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity. Eur J Hum Genet 23:1192\u20131199","journal-title":"Eur J Hum Genet"},{"key":"3241_CR19","first-page":"203","volume":"45","author":"A Bagga","year":"2008","unstructured":"Indian Pediatric Nephrology Group, Indian Academy of Pediatrics, Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, Senguttuvan P, Sethi S, Shah M (2008) Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 45:203\u2013214","journal-title":"Indian Pediatr"},{"key":"3241_CR20","unstructured":"Haute Autorite de Sante (2008) Syndrome nephrotique idiopathique de l\u2019enfant: protocole national de diagnostic et de soins pour une maladie rare. Available at: http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2008-06\/pnds_sni_enfant.pdf"},{"key":"3241_CR21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1440-1754.1998.00232.x","volume":"34","author":"P McIntyre","year":"1998","unstructured":"McIntyre P, Craig JC (1998) Prevention of serious bacterial infection in children with nephrotic syndrome. J Paediatr Child Health 34:314\u2013317","journal-title":"J Paediatr Child Health"},{"key":"3241_CR22","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.V85824","volume":"8","author":"BM Tune","year":"1997","unstructured":"Tune BM, Mendoza SA (1997) Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J Am Soc Nephrol 8:824\u2013832","journal-title":"J Am Soc Nephrol"},{"key":"3241_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.92.2.223","volume":"92","author":"SF Dowell","year":"1993","unstructured":"Dowell SF, Bresee JS (1993) Severe varicella associated with steroid use. Pediatrics 92:223\u2013228","journal-title":"Pediatrics"},{"key":"3241_CR24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0140-6736(69)92330-7","volume":"2","author":"SR Meadow","year":"1969","unstructured":"Meadow SR, Weller RO, Archibald RW (1969) Fatal systemic measles in a child receiving cyclophosphamide for nephrotic syndrome. Lancet 2:876\u2013878","journal-title":"Lancet"},{"key":"3241_CR25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1442-200X.1998.tb01942.x","volume":"40","author":"T Patiroglu","year":"1998","unstructured":"Patiroglu T, Melikoglu A, Dusunsel R (1998) Serum levels of C3 and factors I and B in minimal change disease. Acta Paediatr Jpn 40:333\u2013336","journal-title":"Acta Paediatr Jpn"},{"key":"3241_CR26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639","journal-title":"Lancet"},{"key":"3241_CR27","first-page":"336","volume":"22","author":"S Afroz","year":"2013","unstructured":"Afroz S, Roy DK, Khan AH (2013) Low serum immunglobulin G (IgG) during nephrosis is a predictor of urinary tract infection (UTI) in children with nephrotic syndrome. Mymensingh Med J 22:336\u2013341","journal-title":"Mymensingh Med J"},{"key":"3241_CR28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","volume":"17","author":"MJ Kemper","year":"2002","unstructured":"Kemper MJ, Altrogge H, Ganschow R, Muller-Wiefel DE (2002) Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol 17:413\u2013417","journal-title":"Pediatr Nephrol"},{"key":"3241_CR29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00467-002-0890-6","volume":"17","author":"SR Hingorani","year":"2002","unstructured":"Hingorani SR, Weiss NS, Watkins SL (2002) Predictors of peritonitis in children with nephrotic syndrome. Pediatr Nephrol 17:678\u2013682","journal-title":"Pediatr Nephrol"},{"key":"3241_CR30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1542\/peds.42.4.667","volume":"42","author":"CM Wilfert","year":"1968","unstructured":"Wilfert CM, Katz SL (1968) Etiology of bacterial sepsis in nephrotic children 1963\u20131967. Pediatrics 42:840\u2013843","journal-title":"Pediatrics"},{"key":"3241_CR31","first-page":"555","volume":"90","author":"YK Tsau","year":"1991","unstructured":"Tsau YK, Chen CH, Tsai WS, Sheu JN (1991) Complications of nephrotic syndrome in children. J Formos Med Assoc 90:555\u2013559","journal-title":"J Formos Med Assoc"},{"key":"3241_CR32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1440-1797.2012.01650.x","volume":"17","author":"CC Wei","year":"2012","unstructured":"Wei CC, Yu IW, Lin HW, Tsai AC (2012) Occurrence of infection among children with nephrotic syndrome during hospitalizations. Nephrology (Carlton) 17:681\u2013688","journal-title":"Nephrology (Carlton)"},{"key":"3241_CR33","first-page":"337","volume":"13","author":"KN Moorani","year":"2003","unstructured":"Moorani KN, Khan KM, Ramzan A (2003) Infections in children with nephrotic syndrome. J Coll Physicians Surg Pak 13:337\u2013339","journal-title":"J Coll Physicians Surg Pak"},{"key":"3241_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00866719","volume":"9","author":"S Gulati","year":"1995","unstructured":"Gulati S, Kher V, Gupta A, Arora P, Rai PK, Sharma RK (1995) Spectrum of infections in Indian children with nephrotic syndrome. Pediatr Nephrol 9:431\u2013434","journal-title":"Pediatr Nephrol"},{"key":"3241_CR35","first-page":"19","volume":"24","author":"I Liponski","year":"1995","unstructured":"Liponski I, Cochat P, Gagnadoux MF, Parchoux B, Niaudet P, David L, Broyer M (1995) Bacterial complications of nephrotic syndrome in children. Presse Med 24:19\u201322","journal-title":"Presse Med"},{"key":"3241_CR36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00467-014-2903-7","volume":"30","author":"A Pasini","year":"2015","unstructured":"Pasini A, Aceto G, Ammenti A, Ardissino G, Azzolina V, Bettinelli A, Cama E, Cantatore S, Crisafi A, Conti G, D\u2019Agostino M, Dozza A, Edefonti A, Fede C, Groppali E, Gualeni C, Lavacchini A, Lepore M, Maringhini S, Mariotti P, Materassi M, Mencarelli F, Messina G, Negri A, Piepoli M, Ravaglia F, Simoni A, Spagnoletta L, Montini G (2015) Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol 30:91\u2013101","journal-title":"Pediatr Nephrol"},{"key":"3241_CR37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1745-6215-15-147","volume":"15","author":"NJ Webb","year":"2014","unstructured":"Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ (2014) Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial. Trials 15:147","journal-title":"Trials"},{"key":"3241_CR38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1542\/peds.81.6.849","volume":"81","author":"MJ Gorensek","year":"1988","unstructured":"Gorensek MJ, Lebel MH, Nelson JD (1988) Peritonitis in children with nephrotic syndrome. Pediatrics 81:849\u2013856","journal-title":"Pediatrics"},{"key":"3241_CR39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archpedi.1982.03970440076023","volume":"136","author":"AM Krensky","year":"1982","unstructured":"Krensky AM, Ingelfinger JR, Grupe WE (1982) Peritonitis in childhood nephrotic syndrome: 1970\u20131980. Am J Dis Child 136:732\u2013736","journal-title":"Am J Dis Child"},{"key":"3241_CR40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00431-009-0989-x","volume":"169","author":"N Uncu","year":"2010","unstructured":"Uncu N, Bulbul M, Yildiz N, Noyan A, Kosan C, Kavukcu S, Caliskan S, Gunduz Z, Besbas N, Gur Guven A (2010) Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr 169:73\u201376","journal-title":"Eur J Pediatr"},{"key":"3241_CR41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00006454-199603000-00012","volume":"15","author":"S Gulati","year":"1996","unstructured":"Gulati S, Kher V, Arora P, Gupta S, Kale S (1996) Urinary tract infection in nephrotic syndrome. Pediatr Infect Dis J 15:237\u2013240","journal-title":"Pediatr Infect Dis J"},{"key":"3241_CR42","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s004670050710","volume":"13","author":"YL Tain","year":"1999","unstructured":"Tain YL, Lin G, Cher TW (1999) Microbiological spectrum of septicemia and peritonitis in nephrotic children. Pediatr Nephrol 13:835\u2013837","journal-title":"Pediatr Nephrol"},{"key":"3241_CR43","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/adc.62.9.964","volume":"62","author":"LS Milner","year":"1987","unstructured":"Milner LS, Berkowitz FE, Ngwenya E, Kala U, Jacobs D (1987) Penicillin resistant pneumococcal peritonitis in nephrotic syndrome. Arch Dis Child 62:964\u2013965","journal-title":"Arch Dis Child"},{"key":"3241_CR44","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1399-3046.2006.00583.x","volume":"10","author":"SS Blanchard","year":"2006","unstructured":"Blanchard SS, Gerrek M, Siegel C, Czinn SJ (2006) Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant 10:826\u2013829","journal-title":"Pediatr Transplant"},{"key":"3241_CR45","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/bmj.1.6025.1562","volume":"1","author":"CR Pullan","year":"1976","unstructured":"Pullan CR, Noble TC, Scott DJ, Wisniewsk K, Gardner PS (1976) Atypical measles infections in leukaemic children on immunosuppressive treatment. Br Med J 1:1562\u20131565","journal-title":"Br Med J"},{"key":"3241_CR46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","volume":"21","author":"M Echavarria","year":"2008","unstructured":"Echavarria M (2008) Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 21:704\u2013715","journal-title":"Clin Microbiol Rev"},{"key":"3241_CR47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3476(86)80876-9","volume":"108","author":"NE MacDonald","year":"1986","unstructured":"MacDonald NE, Wolfish N, McLaine P, Phipps P, Rossier E (1986) Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Pediatr 108:378\u2013382","journal-title":"J Pediatr"},{"key":"3241_CR48","first-page":"151","volume":"73","author":"RW Blumberg","year":"1947","unstructured":"Blumberg RW, Cassady HA (1947) Effect of measles on the nephrotic syndrome. Am J Dis Child 73:151\u2013166","journal-title":"Am J Dis Child"},{"key":"3241_CR49","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00467-014-2860-1","volume":"29","author":"C Dossier","year":"2014","unstructured":"Dossier C, Sellier-Leclerc AL, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, Madhi F, Charbit M, Ulinski T, Simon T, Jacqz-Aigrain E, Deschenes G (2014) Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome. Pediatr Nephrol 29:2325\u20132331","journal-title":"Pediatr Nephrol"},{"key":"3241_CR50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/000992288802700807","volume":"27","author":"AY Elzouki","year":"1988","unstructured":"Elzouki AY, Jaiswal OP (1988) Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate. Clin Pediatr (Phila) 27:387\u2013392","journal-title":"Clin Pediatr (Phila)"},{"key":"3241_CR51","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","volume":"314","author":"MH Gaston","year":"1986","unstructured":"Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, Diamond S, Holbrook T, Gill FM, Ritchey K, Falletta JM (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314:1593\u20131599","journal-title":"N Engl J Med"},{"key":"3241_CR52","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-3476(96)70025-2","volume":"129","author":"CF Norris","year":"1996","unstructured":"Norris CF, Mahannah SR, Smith-Whitley K, Ohene-Frempong K, McGowan KL (1996) Pneumococcal colonization in children with sickle cell disease. J Pediatr 129:821\u2013827","journal-title":"J Pediatr"},{"key":"3241_CR53","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3476(96)80130-2","volume":"128","author":"EL Anderson","year":"1996","unstructured":"Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM (1996) Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 128:649\u2013653","journal-title":"J Pediatr"},{"key":"3241_CR54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","volume":"19","author":"S Black","year":"2000","unstructured":"Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187\u2013195","journal-title":"Pediatr Infect Dis J"},{"key":"3241_CR55","first-page":"197","volume":"50","author":"PL Lopalco","year":"2009","unstructured":"Lopalco PL (2009) Childhood pneumococcal vaccination in Europe. J Prev Med Hyg 50:197\u2013200","journal-title":"J Prev Med Hyg"},{"key":"3241_CR56","unstructured":"Department of Health (Public Health England) (2013) Immunisation against infectious disease. Available at: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/266583\/The_Green_book_front_cover_and_contents_page_December_2013.pdf"},{"key":"3241_CR57","doi-asserted-by":"crossref","unstructured":"Davies EG, Riddington C, Lottenberg R, Dower N (2004) Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev 2004(1):CD003885","DOI":"10.1002\/14651858.CD003885.pub2"},{"key":"3241_CR58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1542\/peds.69.2.219","volume":"69","author":"JS Spika","year":"1982","unstructured":"Spika JS, Halsey NA, Fish AJ, Lum GM, Lauer BA, Schiffman G, Giebink GS (1982) Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics 69:219\u2013223","journal-title":"Pediatrics"},{"key":"3241_CR59","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00467-008-0782-5","volume":"23","author":"T Ulinski","year":"2008","unstructured":"Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A (2008) High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatr Nephrol 23:1107\u20131113","journal-title":"Pediatr Nephrol"},{"key":"3241_CR60","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0272-6386(86)80186-X","volume":"7","author":"JS Spika","year":"1986","unstructured":"Spika JS, Halsey NA, Le CT, Fish AJ, Lum GM, Lauer BA, Schiffman G, Giebink GS (1986) Decline of vaccine-induced antipneumococcal antibody in children with nephrotic syndrome. Am J Kidney Dis 7:466\u2013470","journal-title":"Am J Kidney Dis"},{"key":"3241_CR61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00467-003-1331-x","volume":"19","author":"AG Guven","year":"2004","unstructured":"Guven AG, Akman S, Bahat E, Senyurt M, Yuzbey S, Uguz A, Yegin O (2004) Rapid decline of anti-pneumococcal antibody levels in nephrotic children. Pediatr Nephrol 19:61\u201365","journal-title":"Pediatr Nephrol"},{"key":"3241_CR62","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(80)80568-3","volume":"96","author":"DH Moore","year":"1980","unstructured":"Moore DH, Shackelford PG, Robson AM, Rose GM (1980) Recurrent pneumococcal sepsis and defective opsonization after pneumococcal capsular polysaccharide vaccine in a child with nephrotic syndrome. J Pediatr 96:882\u2013885","journal-title":"J Pediatr"},{"key":"3241_CR63","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(79)92421-8","volume":"2","author":"WA Primack","year":"1979","unstructured":"Primack WA, Rosel M, Thirumoorthi MC, Fleischmann LE, Schiffman G (1979) Failure of pneumococcal vaccine to prevent Streptococcus pneumoniae sepsis in nephrotic children. Lancet 2:1192","journal-title":"Lancet"},{"key":"3241_CR64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/clinids\/17.2.244","volume":"17","author":"P Ljungman","year":"1993","unstructured":"Ljungman P, Andersson J, Aschan J, Barkholt L, Ehrnst A, Johansson M, Weiland O (1993) Influenza A in immunocompromised patients. Clin Infect Dis 17:244\u2013247","journal-title":"Clin Infect Dis"},{"key":"3241_CR65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00467-003-1301-3","volume":"19","author":"HM Poyrazoglu","year":"2004","unstructured":"Poyrazoglu HM, Dusunsel R, Gunduz Z, Patiroglu T, Koklu S (2004) Antibody response to influenza A vaccination in children with nephrotic syndrome. Pediatr Nephrol 19:57\u201360","journal-title":"Pediatr Nephrol"},{"key":"3241_CR66","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archpedi.1983.02140350057014","volume":"137","author":"ER Morgan","year":"1983","unstructured":"Morgan ER, Smalley LA (1983) Varicella in immunocompromised children. Incidence of abdominal pain and organ involvement. Am J Dis Child 137:883\u2013885","journal-title":"Am J Dis Child"},{"key":"3241_CR67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08880010801938215","volume":"25","author":"A Matsuzaki","year":"2008","unstructured":"Matsuzaki A, Suminoe A, Koga Y, Kusuhara K, Hara T, Ogata R, Sata T, Hara T (2008) Fatal visceral varicella-zoster virus infection without skin involvement in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 25:237\u2013242","journal-title":"Pediatr Hematol Oncol"},{"key":"3241_CR68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3476(97)70094-5","volume":"131","author":"RM Quien","year":"1997","unstructured":"Quien RM, Kaiser BA, Deforest A, Polinsky MS, Fisher M, Baluarte HJ (1997) Response to the varicella vaccine in children with nephrotic syndrome. J Pediatr 131:688\u2013690","journal-title":"J Pediatr"},{"key":"3241_CR69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mpd.2003.37","volume":"142","author":"SL Furth","year":"2003","unstructured":"Furth SL, Arbus GS, Hogg R, Tarver J, Chan C, Fivush BA (2003) Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group. J Pediatr 142:145\u2013148","journal-title":"J Pediatr"},{"key":"3241_CR70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00467-001-0789-7","volume":"17","author":"H Alpay","year":"2002","unstructured":"Alpay H, Yildiz N, Onar A, Temizer H, Ozcay S (2002) Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 17:181\u2013183","journal-title":"Pediatr Nephrol"},{"key":"3241_CR71","doi-asserted-by":"crossref","first-page":"e820","DOI":"10.1542\/peds.2008-3310","volume":"123","author":"D Perella","year":"2009","unstructured":"Perella D, Fiks AG, Jumaan A, Robinson D, Gargiullo P, Pletcher J, Forke CM, Schmid DS, Renwick M, Mankodi F, Watson B, Spain CV (2009) Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era. Pediatrics 123:e820\u2013e828","journal-title":"Pediatrics"},{"key":"3241_CR72","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Seward JF (2007) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56:1\u201340","journal-title":"MMWR Recomm Rep"},{"key":"3241_CR73","unstructured":"Peters G (ed) (1997) Red book Report of the Committee on Infectious Diseases, 24th edn. American Academy of Pediatrics, Elk Grove Village"},{"key":"3241_CR74","unstructured":"Centers for Disease Control and Prevention (CDC) (2012) FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella. MMWR Morb Mortal Wkly Rep 61:212"},{"key":"3241_CR75","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1542\/peds.50.5.718","volume":"50","author":"PA Brunell","year":"1972","unstructured":"Brunell PA, Gershon AA, Hughes WT, Riley HD Jr, Smith J (1972) Prevention of varicella in high risk children: a collaborative study. Pediatrics 50:718\u2013722","journal-title":"Pediatrics"},{"key":"3241_CR76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM197401312900503","volume":"290","author":"AA Gershon","year":"1974","unstructured":"Gershon AA, Steinberg S, Brunell PA (1974) Zoster immune globulin. A further assessment. N Engl J Med 290:243\u2013245","journal-title":"N Engl J Med"},{"key":"3241_CR77","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/infdis\/147.4.737","volume":"147","author":"JA Zaia","year":"1983","unstructured":"Zaia JA, Levin MJ, Preblud SR, Leszczynski J, Wright GG, Ellis RJ, Curtis AC, Valerio MA, LeGore J (1983) Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis 147:737\u2013743","journal-title":"J Infect Dis"},{"key":"3241_CR78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1542\/peds.92.2.219","volume":"92","author":"Y Asano","year":"1993","unstructured":"Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T, Ozaki T, Yamada A, Imanishi J (1993) Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92:219\u2013222","journal-title":"Pediatrics"},{"key":"3241_CR79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004670050764","volume":"14","author":"SL Goldstein","year":"2000","unstructured":"Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL (2000) Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediatr Nephrol 14:305\u2013308","journal-title":"Pediatr Nephrol"},{"key":"3241_CR80","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2006-1612","volume":"119","author":"DI Shulman","year":"2007","unstructured":"Shulman DI, Palmert MR, Kemp SF (2007) Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics 119:e484\u2013e494","journal-title":"Pediatrics"},{"key":"3241_CR81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mpd.2000.107385","volume":"137","author":"EI Felner","year":"2000","unstructured":"Felner EI, Thompson MT, Ratliff AF, White PC, Dickson BA (2000) Time course of recovery of adrenal function in children treated for leukemia. J Pediatr 137:21\u201324","journal-title":"J Pediatr"},{"key":"3241_CR82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/adc.2006.108985","volume":"92","author":"AS Abeyagunawardena","year":"2007","unstructured":"Abeyagunawardena AS, Hindmarsh P, Trompeter RS (2007) Adrenocortical suppression increases the risk of relapse in nephrotic syndrome. Arch Dis Child 92:585\u2013588","journal-title":"Arch Dis Child"},{"key":"3241_CR83","first-page":"126","volume":"77","author":"A Sumboonnanonda","year":"1994","unstructured":"Sumboonnanonda A, Vongjirad A, Suntornpoch V, Petrarat S (1994) Adrenal function after prednisolone treatment in childhood nephrotic syndrome. J Med Assoc Thail 77:126\u2013129","journal-title":"J Med Assoc Thail"},{"key":"3241_CR84","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(89)91266-X","volume":"1","author":"MA Lewis","year":"1989","unstructured":"Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ (1989) Nephrotic syndrome: from toddlers to twenties. Lancet 1:255\u2013259","journal-title":"Lancet"},{"key":"3241_CR85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjmed.2007.08.042","volume":"121","author":"F Kayali","year":"2008","unstructured":"Kayali F, Najjar R, Aswad F, Matta F, Stein PD (2008) Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 121:226\u2013230","journal-title":"Am J Med"},{"key":"3241_CR86","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ki.1983.28","volume":"23","author":"RD Wagoner","year":"1983","unstructured":"Wagoner RD, Stanson AW, Holley KE, Winter CS (1983) Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int 23:368\u2013374","journal-title":"Kidney Int"},{"key":"3241_CR87","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000167654","volume":"8","author":"F Velasquez Forero","year":"1988","unstructured":"Velasquez Forero F, Garcia Prugue N, Ruiz Morales N (1988) Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol 8:457\u2013462","journal-title":"Am J Nephrol"},{"key":"3241_CR88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00003072-200003000-00001","volume":"25","author":"SC Cherng","year":"2000","unstructured":"Cherng SC, Huang WS, Wang YF, Yang SP, Lin YF (2000) The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism. Clin Nucl Med 25:167\u2013172","journal-title":"Clin Nucl Med"},{"key":"3241_CR89","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2007.10.030","volume":"51","author":"WE Wysokinski","year":"2008","unstructured":"Wysokinski WE, Gosk-Bierska I, Greene EL, Grill D, Wiste H, McBane RD 2nd (2008) Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis 51:224\u2013232","journal-title":"Am J Kidney Dis"},{"issue":"Suppl","key":"3241_CR90","first-page":"20","volume":"30","author":"F Egli","year":"1973","unstructured":"Egli F, Elmiger P, Stalder G (1973) Thrombosis as a complication of nephrotic syndrome. Helv Paediatr Acta 30[Suppl]:20\u201321","journal-title":"Helv Paediatr Acta"},{"key":"3241_CR91","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-3476(84)80418-7","volume":"105","author":"JD Mahan","year":"1984","unstructured":"Mahan JD, Mauer SM, Sibley RK, Vernier RL (1984) Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr 105:549\u2013557","journal-title":"J Pediatr"},{"key":"3241_CR92","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1651-2227.1986.tb10294.x","volume":"75","author":"PF Hoyer","year":"1986","unstructured":"Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J (1986) Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand 75:804\u2013810","journal-title":"Acta Paediatr Scand"},{"key":"3241_CR93","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0022-3476(87)80397-9","volume":"110","author":"O Mehls","year":"1987","unstructured":"Mehls O, Andrassy K, Koderisch J, Herzog U, Ritz E (1987) Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. J Pediatr 110:862\u2013867","journal-title":"J Pediatr"},{"key":"3241_CR94","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-996100","volume":"23","author":"N Schlegel","year":"1997","unstructured":"Schlegel N (1997) Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost 23:271\u2013280","journal-title":"Semin Thromb Hemost"},{"key":"3241_CR95","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s004670050029","volume":"14","author":"A Citak","year":"2000","unstructured":"Citak A, Emre S, Sairin A, Bilge I, Nayir A (2000) Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol 14:138\u2013142","journal-title":"Pediatr Nephrol"},{"key":"3241_CR96","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s004679900253","volume":"15","author":"MI Lilova","year":"2000","unstructured":"Lilova MI, Velkovski IG, Topalov IB (2000) Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974\u20131996). Pediatr Nephrol 15:74\u201378","journal-title":"Pediatr Nephrol"},{"key":"3241_CR97","first-page":"104","volume":"14","author":"RM Hamed","year":"2001","unstructured":"Hamed RM, Shomaf M (2001) Congenital nephrotic syndrome: a clinico-pathologic study of thirty children. J Nephrol 14:104\u2013109","journal-title":"J Nephrol"},{"key":"3241_CR98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpeds.2009.01.070","volume":"155","author":"BA Kerlin","year":"2009","unstructured":"Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE (2009) Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr 155:105\u2013110","journal-title":"J Pediatr"},{"key":"3241_CR99","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE (2012) Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 7:513\u2013520","journal-title":"Clin J Am Soc Nephrol"},{"key":"3241_CR100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10157-013-0917-2","volume":"18","author":"D Suri","year":"2014","unstructured":"Suri D, Ahluwalia J, Saxena AK, Sodhi KS, Singh P, Mittal BR, Das R, Rawat A, Singh S (2014) Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol 18:803\u2013813","journal-title":"Clin Exp Nephrol"},{"key":"3241_CR101","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2141.2010.08206.x","volume":"149","author":"WM Lijfering","year":"2010","unstructured":"Lijfering WM, Rosendaal FR, Cannegieter SC (2010) Risk factors for venous thrombosis\u2014current understanding from an epidemiological point of view. Br J Haematol 149:824\u2013833","journal-title":"Br J Haematol"},{"key":"3241_CR102","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5414\/CN107863","volume":"79","author":"M Sahin","year":"2013","unstructured":"Sahin M, Ozkurt S, Degirmenci NA, Musmul A, Temiz G, Soydan M (2013) Assessment of genetic risk factors for thromboembolic complications in adults with idiopathic nephrotic syndrome. Clin Nephrol 79:454\u2013462","journal-title":"Clin Nephrol"},{"key":"3241_CR103","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1055\/s-0037-1614859","volume":"82","author":"JP Colle","year":"1999","unstructured":"Colle JP, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, Bensman A, Soria J, Soria C (1999) Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost 82:1482\u20131489","journal-title":"Thromb Haemost"},{"key":"3241_CR104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2004.05329.x","volume":"129","author":"C Dame","year":"2005","unstructured":"Dame C, Sutor AH (2005) Primary and secondary thrombocytosis in childhood. Br J Haematol 129:165\u2013177","journal-title":"Br J Haematol"},{"key":"3241_CR105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jth.12891","volume":"13","author":"B Eneman","year":"2015","unstructured":"Eneman B, Freson K, van den Heuvel L, van Hoyweghen E, Collard L, Vande Walle J, van Geet C, Levtchenko E (2015) Pituitary adenylate cyclase-activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome. J Thromb Haemost 13:755\u2013767","journal-title":"J Thromb Haemost"},{"key":"3241_CR106","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1440-1797.2012.01575.x","volume":"17","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z (2012) Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton) 17:338\u2013345","journal-title":"Nephrology (Carlton)"},{"key":"3241_CR107","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00467-013-2525-5","volume":"29","author":"BA Kerlin","year":"2014","unstructured":"Kerlin BA, Haworth K, Smoyer WE (2014) Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol 29:989\u2013997","journal-title":"Pediatr Nephrol"},{"key":"3241_CR108","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0736-4679(01)00359-6","volume":"21","author":"SM Cueto","year":"2001","unstructured":"Cueto SM, Cavanaugh SH, Benenson RS, Redclift MS (2001) Computed tomography scan versus ventilation-perfusion lung scan in the detection of pulmonary embolism. J Emerg Med 21:155\u2013164","journal-title":"J Emerg Med"},{"key":"3241_CR109","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.acra.2011.11.002","volume":"19","author":"LJ Zhang","year":"2012","unstructured":"Zhang LJ, Wang ZJ, Zhou CS, Lu L, Luo S, Lu GM (2012) Evaluation of pulmonary embolism in pediatric patients with nephrotic syndrome with dual energy CT pulmonary angiography. Acad Radiol 19:341\u2013348","journal-title":"Acad Radiol"},{"key":"3241_CR110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s004310050972","volume":"157","author":"D Fabri","year":"1998","unstructured":"Fabri D, Belangero VM, Annichino-Bizzacchi JM, Arruda VR (1998) Inherited risk factors for thrombophilia in children with nephrotic syndrome. Eur J Pediatr 157:939\u2013942","journal-title":"Eur J Pediatr"},{"key":"3241_CR111","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","volume":"141","author":"P Monagle","year":"2012","unstructured":"Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Gottl U, Vesely SK (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e737S\u2013e801S","journal-title":"Chest"},{"key":"3241_CR112","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.2009.07820.x","volume":"147","author":"L Raffini","year":"2009","unstructured":"Raffini L, Thornburg C (2009) Testing children for inherited thrombophilia: more questions than answers. Br J Haematol 147:277\u2013288","journal-title":"Br J Haematol"},{"key":"3241_CR113","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","volume":"18","author":"RJ Glassock","year":"2007","unstructured":"Glassock RJ (2007) Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. J Am Soc Nephrol 18:2221\u20132225","journal-title":"J Am Soc Nephrol"},{"key":"3241_CR114","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10157-014-1005-y","volume":"19","author":"B Tavil","year":"2015","unstructured":"Tavil B, Kara F, Topaloglu R, Aytac S, Unal S, Kuskonmaz B, Cetin M, Besbas N, Gumruk F (2015) Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience. Clin Exp Nephrol 19:506\u2013513","journal-title":"Clin Exp Nephrol"},{"key":"3241_CR115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00128072-200305050-00006","volume":"5","author":"E Hodson","year":"2003","unstructured":"Hodson E (2003) The management of idiopathic nephrotic syndrome in children. Paediatr Drugs 5:335\u2013349","journal-title":"Paediatr Drugs"},{"key":"3241_CR116","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","volume":"338","author":"SR Orth","year":"1998","unstructured":"Orth SR, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338:1202\u20131211","journal-title":"N Engl J Med"},{"key":"3241_CR117","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.thromres.2010.12.020","volume":"127","author":"M Resh","year":"2011","unstructured":"Resh M, Mahmoodi BK, Navis GJ, Veeger NJ, Lijfering WM (2011) Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism. Thromb Res 127:395\u2013399","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"3241_CR118","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/ajh.23131","volume":"87","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA (2012) Current and future management of pediatric venous thromboembolism. Am J Hematol 87[Suppl 1]:S68\u2013S74","journal-title":"Am J Hematol"},{"key":"3241_CR119","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1537-2995.2003.00315.x","volume":"43","author":"BA Konkle","year":"2003","unstructured":"Konkle BA, Bauer KA, Weinstein R, Greist A, Holmes HE, Bonfiglio J (2003) Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Transfusion (Paris) 43:390\u2013394","journal-title":"Transfusion (Paris)"},{"key":"3241_CR120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1590\/S0103-05822008000200015","volume":"26","author":"P Meirelles","year":"2008","unstructured":"Meirelles P, Watanabe A, Carneiro J, Koch V (2008) Peculiaridades da terapia trombol\u00edtica na s\u00edndrome nefr\u00f3tica pedi\u00e1trica: monitoriza\u00e7\u00e3o do fator anti-Xa. Rev Paul Pediatr 26:183\u2013187","journal-title":"Rev Paul Pediatr"},{"key":"3241_CR121","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/asheducation-2013.1.464","volume":"2013","author":"KA Bauer","year":"2013","unstructured":"Bauer KA (2013) Pros and cons of new oral anticoagulants. Hematol Am Soc Hematol Educ Program 2013:464\u2013470","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3241_CR122","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","volume":"118","author":"R Singhal","year":"2006","unstructured":"Singhal R, Brimble KS (2006) Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 118:397\u2013407","journal-title":"Thromb Res"},{"key":"3241_CR123","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrcardio.2010.141","volume":"7","author":"J Es van","year":"2010","unstructured":"van Es J, Douma RA, Gerdes VE, Kamphuisen PW, Buller HR (2010) Acute pulmonary embolism. Part 2: treatment. Nat Rev Cardiol 7:613\u2013622","journal-title":"Nat Rev Cardiol"},{"key":"3241_CR124","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/1076029613480557","volume":"19","author":"A Chander","year":"2013","unstructured":"Chander A, Nagel K, Wiernikowski J, Paes B, Chan AK, Thrombosis and Hemostasis in Newborns (THiN) Group (2013) Evaluation of the use of low-molecular-weight heparin in neonates: a retrospective, single-center study. Clin Appl Thromb Hemost 19:488\u2013493","journal-title":"Clin Appl Thromb Hemost"},{"key":"3241_CR125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00852846","volume":"5","author":"CL Jones","year":"1991","unstructured":"Jones CL, Hebert D (1991) Pulmonary thrombo-embolism in the nephrotic syndrome. Pediatr Nephrol 5:56\u201358","journal-title":"Pediatr Nephrol"},{"key":"3241_CR126","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s004310050684","volume":"156","author":"CJ Reid","year":"1997","unstructured":"Reid CJ, Segal T (1997) Pulmonary thrombo-embolism in nephrotic syndrome treated with tissue plasminogen activator. Eur J Pediatr 156:647\u2013649","journal-title":"Eur J Pediatr"},{"key":"3241_CR127","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-013-2687-1","volume":"29","author":"M Shimizu","year":"2014","unstructured":"Shimizu M, Ishikawa S, Yachi Y, Muraoka M, Tasaki Y, Iwasaki H, Kuroda M, Ohta K, Yachie A (2014) Tolvaptan therapy for massive edema in a patient with nephrotic syndrome. Pediatr Nephrol 29:915\u2013917","journal-title":"Pediatr Nephrol"},{"key":"3241_CR128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(95)91210-X","volume":"346","author":"JG Vande Walle","year":"1995","unstructured":"Vande Walle JG, Donckerwolcke RA, van Isselt JW, Derkx FH, Joles JA, Koomans HA (1995) Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 346:148\u2013152","journal-title":"Lancet"},{"key":"3241_CR129","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/ki.1996.207","volume":"49","author":"J Vande Walle","year":"1996","unstructured":"Vande Walle J, Donckerwolcke R, Boer P, van Isselt HW, Koomans HA, Joles JA (1996) Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney Int 49:1471\u20131477","journal-title":"Kidney Int"},{"key":"3241_CR130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000183302","volume":"38","author":"AB Geers","year":"1984","unstructured":"Geers AB, Koomans HA, Boer P, Dorhout Mees EJ (1984) Plasma and blood volumes in patients with the nephrotic syndrome. Nephron 38:170\u2013173","journal-title":"Nephron"},{"key":"3241_CR131","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-9343(52)90020-X","volume":"13","author":"AA Epstein","year":"1952","unstructured":"Epstein AA (1952) Concerning the causation of edema in chronic parenchymatous nephritis; method for its alleviation. Am J Med 13:556\u2013561","journal-title":"Am J Med"},{"key":"3241_CR132","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-91-5-688","volume":"91","author":"JI Meltzer","year":"1979","unstructured":"Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S (1979) Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 91:688\u2013696","journal-title":"Ann Intern Med"},{"key":"3241_CR133","first-page":"S21","volume":"59","author":"BF Palmer","year":"1997","unstructured":"Palmer BF, Alpern RJ (1997) Pathogenesis of edema formation in the nephrotic syndrome. Kidney Int Suppl 59:S21\u2013S27","journal-title":"Kidney Int Suppl"},{"key":"3241_CR134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000188535","volume":"70","author":"EJ Dorhout Mees","year":"1995","unstructured":"Dorhout Mees EJ, Koomans HA (1995) Understanding the nephrotic syndrome: what\u2019s new in a decade? Nephron 70:1\u201310","journal-title":"Nephron"},{"key":"3241_CR135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ki.1994.33","volume":"45","author":"MH Humphreys","year":"1994","unstructured":"Humphreys MH (1994) Mechanisms and management of nephrotic edema. Kidney Int 45:266\u2013281","journal-title":"Kidney Int"},{"key":"3241_CR136","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1046\/j.1523-1755.1998.00864.x","volume":"53","author":"RW Schrier","year":"1998","unstructured":"Schrier RW, Fassett RG (1998) A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int 53:1111\u20131117","journal-title":"Kidney Int"},{"key":"3241_CR137","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2215\/CJN.04390808","volume":"4","author":"G Kapur","year":"2009","unstructured":"Kapur G, Valentini RP, Imam AA, Mattoo TK (2009) Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study. Clin J Am Soc Nephrol 4:907\u2013913","journal-title":"Clin J Am Soc Nephrol"},{"key":"3241_CR138","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0971-4065.83027","volume":"21","author":"M Sahay","year":"2011","unstructured":"Sahay M (2011) Urinary indices in nephrotic syndrome. Indian J Nephrol 21:152\u2013153","journal-title":"Indian J Nephrol"},{"key":"3241_CR139","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1681\/ASN.V102323","volume":"10","author":"JG Vande Walle","year":"1999","unstructured":"Vande Walle JG, Donckerwolcke RA, Koomans HA (1999) Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 10:323\u2013331","journal-title":"J Am Soc Nephrol"},{"key":"3241_CR140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s004670000512","volume":"16","author":"JG Vande Walle","year":"2001","unstructured":"Vande Walle JG, Donckerwolcke RA (2001) Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 16:283\u2013293","journal-title":"Pediatr Nephrol"},{"key":"3241_CR141","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00467-013-2567-8","volume":"29","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai MA, Tkachenko O, Shchekochikhin D, Schrier RW (2014) The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr Nephrol 29:1159\u20131167","journal-title":"Pediatr Nephrol"},{"key":"3241_CR142","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.62.5.811","volume":"62","author":"MA Engle","year":"1978","unstructured":"Engle MA, Lewy JE, Lewy PR, Metcoff J (1978) The use of furosemide in the treatment of edema in infants and children. Pediatrics 62:811\u2013818","journal-title":"Pediatrics"},{"key":"3241_CR143","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ki.1991.43","volume":"39","author":"BD Rose","year":"1991","unstructured":"Rose BD (1991) Diuretics. Kidney Int 39:336\u2013352","journal-title":"Kidney Int"},{"key":"3241_CR144","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/cpt1977212234","volume":"21","author":"GR Lang","year":"1977","unstructured":"Lang GR, Westenfelder C, Nascimento L, Dhupelia VB, Arruda JA, Kane RE (1977) Metolazone and spironolactone in cirrhosis and the nephrotic syndrome. Clin Pharmacol Ther 21:234\u2013243","journal-title":"Clin Pharmacol Ther"},{"key":"3241_CR145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1440-1681.1975.tb01834.x","volume":"2","author":"GJ Schapel","year":"1975","unstructured":"Schapel GJ, Edwards DG, Robinson J (1975) Potassium-sparing effect of amiloride in a diuretic factorial study in man. Clin Exp Pharmacol Physiol 2:277\u2013287","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3241_CR146","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.91.6.1142","volume":"91","author":"RM Haws","year":"1993","unstructured":"Haws RM, Baum M (1993) Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 91:1142\u20131146","journal-title":"Pediatrics"},{"key":"3241_CR147","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/bmj.312.7022.36","volume":"312","author":"CJ Reid","year":"1996","unstructured":"Reid CJ, Marsh MJ, Murdoch IM, Clark G (1996) Nephrotic syndrome in childhood complicated by life threatening pulmonary oedema. BMJ 312:36\u201338","journal-title":"BMJ"},{"key":"3241_CR148","first-page":"216","volume":"7","author":"GM Liumbruno","year":"2009","unstructured":"Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G (2009) Recommendations for the use of albumin and immunoglobulins. Blood Transfus 7:216\u2013234","journal-title":"Blood Transfus"},{"key":"3241_CR149","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2362.1985.tb00139.x","volume":"15","author":"EB Pedersen","year":"1985","unstructured":"Pedersen EB, Danielsen H, Madsen M, Jensen T (1985) Defective renal water excretion in nephrotic syndrome: the relationship between renal water excretion and kidney function, arginine vasopressin, angiotensin II and aldosterone in plasma before and after oral water loading. Eur J Clin Invest 15:24\u201329","journal-title":"Eur J Clin Invest"},{"key":"3241_CR150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0272-6386(95)90626-6","volume":"25","author":"HJ Pyo","year":"1995","unstructured":"Pyo HJ, Summer SN, Niederberger M, Kim JK, Schrier RW (1995) Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndrome. Am J Kidney Dis 25:58\u201362","journal-title":"Am J Kidney Dis"},{"key":"3241_CR151","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.2008040364","volume":"20","author":"P Svenningsen","year":"2009","unstructured":"Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skott O (2009) Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 20:299\u2013310","journal-title":"J Am Soc Nephrol"},{"key":"3241_CR152","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/apha.12047","volume":"207","author":"P Svenningsen","year":"2013","unstructured":"Svenningsen P, Friis UG, Versland JB, Buhl KB, Moller Frederiksen B, Andersen H, Zachar RM, Bistrup C, Skott O, Jorgensen JS, Andersen RF, Jensen BL (2013) Mechanisms of renal NaCl retention in proteinuric disease. Acta Physiol (Oxf) 207:536\u2013545","journal-title":"Acta Physiol (Oxf)"},{"key":"3241_CR153","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3476(84)80590-9","volume":"104","author":"G Zilleruelo","year":"1984","unstructured":"Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J (1984) Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr 104:61\u201364","journal-title":"J Pediatr"},{"key":"3241_CR154","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1046\/j.1523-1755.2002.00319.x","volume":"61","author":"ND Vaziri","year":"2002","unstructured":"Vaziri ND, Liang K (2002) Up-regulation of acyl-coenzyme A: cholesterol acyltransferase (ACAT) in nephrotic syndrome. Kidney Int 61:1769\u20131775","journal-title":"Kidney Int"},{"key":"3241_CR155","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1053\/ajkd.2001.20766","volume":"37","author":"GC Shearer","year":"2001","unstructured":"Shearer GC, Kaysen GA (2001) Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms. Am J Kidney Dis 37:S119\u2013S122","journal-title":"Am J Kidney Dis"},{"key":"3241_CR156","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1523-1755.2001.00478.x","volume":"59","author":"GC Shearer","year":"2001","unstructured":"Shearer GC, Stevenson FT, Atkinson DN, Jones H, Staprans I, Kaysen GA (2001) Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int 59:179\u2013189","journal-title":"Kidney Int"},{"key":"3241_CR157","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, Chugh SS (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117\u2013122","journal-title":"Nat Med"},{"key":"3241_CR158","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s004670050568","volume":"13","author":"U Querfeld","year":"1999","unstructured":"Querfeld U (1999) Should hyperlipidemia in children with the nephrotic syndrome be treated? Pediatr Nephrol 13:77\u201384","journal-title":"Pediatr Nephrol"},{"key":"3241_CR159","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF00866337","volume":"8","author":"L Hopp","year":"1994","unstructured":"Hopp L, Gilboa N, Kurland G, Weichler N, Orchard TJ (1994) Acute myocardial infarction in a young boy with nephrotic syndrome: a case report and review of the literature. Pediatr Nephrol 8:290\u2013294","journal-title":"Pediatr Nephrol"},{"key":"3241_CR160","first-page":"976","volume":"131","author":"RJ Kallen","year":"1977","unstructured":"Kallen RJ, Brynes RK, Aronson AJ, Lichtig C, Spargo BH (1977) Premature coronary atherosclerosis in a 5-year-old with corticosteroid-refractory nephrotic syndrome. Am J Dis Child 131:976\u2013980","journal-title":"Am J Dis Child"},{"key":"3241_CR161","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0272-6386(12)70179-8","volume":"22","author":"J Radhakrishnan","year":"1993","unstructured":"Radhakrishnan J, Appel AS, Valeri A, Appel GB (1993) The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis 22:135\u2013142","journal-title":"Am J Kidney Dis"},{"key":"3241_CR162","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00467-004-1460-x","volume":"19","author":"BL Lechner","year":"2004","unstructured":"Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ (2004) The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 19:744\u2013748","journal-title":"Pediatr Nephrol"},{"key":"3241_CR163","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1046\/j.1523-1755.1999.07128.x","volume":"71","author":"CJ Olbricht","year":"1999","unstructured":"Olbricht CJ, Wanner C, Thiery J, Basten A (1999) Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group. Kidney Int Suppl 71:S113\u2013S116","journal-title":"Kidney Int Suppl"},{"key":"3241_CR164","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1440-1797.2003.00143.x","volume":"8","author":"P Valdivielso","year":"2003","unstructured":"Valdivielso P, Moliz M, Valera A, Corrales MA, Sanchez-Chaparro MA, Gonzalez-Santos P (2003) Atorvastatin in dyslipidaemia of the nephrotic syndrome. Nephrology (Carlton) 8:61\u201364","journal-title":"Nephrology (Carlton)"},{"key":"3241_CR165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2006.09.030","volume":"195","author":"C Arambepola","year":"2007","unstructured":"Arambepola C, Farmer AJ, Perera R, Neil HA (2007) Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. Atherosclerosis 195:339\u2013347","journal-title":"Atherosclerosis"},{"key":"3241_CR166","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1203\/00006450-199606000-00016","volume":"39","author":"JC Reijneveld","year":"1996","unstructured":"Reijneveld JC, Koot RW, Bredman JJ, Joles JA, Bar PR (1996) Differential effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on the development of myopathy in young rats. Pediatr Res 39:1028\u20131035","journal-title":"Pediatr Res"},{"issue":"Suppl 1","key":"3241_CR167","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ndt\/5.suppl_1.75","volume":"5","author":"G Barsotti","year":"1990","unstructured":"Barsotti G, Cupisti A, Morelli E, Ciardella F, Giovannetti S (1990) Vegan supplemented diet in nephrotic syndrome. Nephrol Dial Transplant 5[Suppl 1]:75\u201377","journal-title":"Nephrol Dial Transplant"},{"key":"3241_CR168","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000168342","volume":"11","author":"G Barsotti","year":"1991","unstructured":"Barsotti G, Morelli E, Cupisti A, Bertoncini P, Giovannetti S (1991) A special, supplemented 'vegan' diet for nephrotic patients. Am J Nephrol 11:380\u2013385","journal-title":"Am J Nephrol"},{"key":"3241_CR169","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.ajkd.2003.08.012","volume":"42","author":"M Hattori","year":"2003","unstructured":"Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K (2003) A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis 42:1121\u20131130","journal-title":"Am J Kidney Dis"},{"key":"3241_CR170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/adc.43.231.589","volume":"43","author":"CN Lam","year":"1968","unstructured":"Lam CN, Arneil GC (1968) Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis. Arch Dis Child 43:589\u2013594","journal-title":"Arch Dis Child"},{"key":"3241_CR171","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/000992288602500304","volume":"25","author":"RJ Merritt","year":"1986","unstructured":"Merritt RJ, Hack SL, Kalsch M, Olson D (1986) Corticosteroid therapy-induced obesity in children. Clin Pediatr (Phila) 25:149\u2013152","journal-title":"Clin Pediatr (Phila)"},{"key":"3241_CR172","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(85)90851-7","volume":"2","author":"KD Foote","year":"1985","unstructured":"Foote KD, Brocklebank JT, Meadow SR (1985) Height attainment in children with steroid-responsive nephrotic syndrome. Lancet 2:917\u2013919","journal-title":"Lancet"},{"key":"3241_CR173","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1651-2227.1998.tb01501.x","volume":"87","author":"MT Saha","year":"1998","unstructured":"Saha MT, Laippala P, Lenko HL (1998) Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone. Acta Paediatr 87:545\u2013548","journal-title":"Acta Paediatr"},{"key":"3241_CR174","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-003-1176-3","volume":"18","author":"F Emma","year":"2003","unstructured":"Emma F, Sesto A, Rizzoni G (2003) Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol 18:783\u2013788","journal-title":"Pediatr Nephrol"},{"key":"3241_CR175","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/adc.63.5.484","volume":"63","author":"L Rees","year":"1988","unstructured":"Rees L, Greene SA, Adlard P, Jones J, Haycock GB, Rigden SP, Preece M, Chantler C (1988) Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child 63:484\u2013490","journal-title":"Arch Dis Child"},{"key":"3241_CR176","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0272-6386(87)80087-2","volume":"9","author":"JS Berns","year":"1987","unstructured":"Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ (1987) Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis 9:108\u2013114","journal-title":"Am J Kidney Dis"},{"key":"3241_CR177","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.84.3.495","volume":"84","author":"R Padilla","year":"1989","unstructured":"Padilla R, Brem AS (1989) Linear growth of children with nephrotic syndrome: effect of alkylating agents. Pediatrics 84:495\u2013499","journal-title":"Pediatrics"},{"key":"3241_CR178","first-page":"422","volume":"39","author":"YT Hung","year":"2006","unstructured":"Hung YT, Yang LY (2006) Follow-up of linear growth of body height in children with nephrotic syndrome. J Microbiol Immunol Infect 39:422\u2013425","journal-title":"J Microbiol Immunol Infect"},{"key":"3241_CR179","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/adc.2007.129957","volume":"95","author":"J Simmonds","year":"2010","unstructured":"Simmonds J, Grundy N, Trompeter R, Tullus K (2010) Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome. Arch Dis Child 95:146\u2013149","journal-title":"Arch Dis Child"},{"key":"3241_CR180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(77)92498-9","volume":"2","author":"JM Barragry","year":"1977","unstructured":"Barragry JM, France MW, Carter ND, Auton JA, Beer M, Boucher BJ, Cohen RD (1977) Vitamin-D metabolism in nephrotic syndrome. Lancet 2:629\u2013632","journal-title":"Lancet"},{"key":"3241_CR181","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.1780271205","volume":"27","author":"JR Hooyman","year":"1984","unstructured":"Hooyman JR, Melton LJ 3rd, Nelson AM, O\u2019Fallon WM, Riggs BL (1984) Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum 27:1353\u20131361","journal-title":"Arthritis Rheum"},{"key":"3241_CR182","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0272-6386(03)00348-2","volume":"41","author":"S Gulati","year":"2003","unstructured":"Gulati S, Godbole M, Singh U, Gulati K, Srivastava A (2003) Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis 41:1163\u20131169","journal-title":"Am J Kidney Dis"},{"key":"3241_CR183","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1523-1755.2005.00690.x","volume":"68","author":"J Hegarty","year":"2005","unstructured":"Hegarty J, Mughal MZ, Adams J, Webb NJ (2005) Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome. Kidney Int 68:2304\u20132309","journal-title":"Kidney Int"},{"key":"3241_CR184","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMoa040367","volume":"351","author":"MB Leonard","year":"2004","unstructured":"Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351:868\u2013875","journal-title":"N Engl J Med"},{"key":"3241_CR185","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1996) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. Arthritis Rheum 39:1791\u20131801","DOI":"10.1002\/art.1780391104"},{"key":"3241_CR186","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/ndt\/gfh809","volume":"20","author":"S Gulati","year":"2005","unstructured":"Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A (2005) Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant 20:1598\u20131603","journal-title":"Nephrol Dial Transplant"},{"key":"3241_CR187","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-08-0837","volume":"160","author":"P Iglesias","year":"2009","unstructured":"Iglesias P, Diez JJ (2009) Thyroid dysfunction and kidney disease. Eur J Endocrinol 160:503\u2013515","journal-title":"Eur J Endocrinol"},{"key":"3241_CR188","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/ndt\/gfr665","volume":"27","author":"A Dagan","year":"2012","unstructured":"Dagan A, Cleper R, Krause I, Blumenthal D, Davidovits M (2012) Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 27:2171\u20132175","journal-title":"Nephrol Dial Transplant"},{"key":"3241_CR189","first-page":"407","volume":"20","author":"S Afroz","year":"2011","unstructured":"Afroz S, Khan AH, Roy DK (2011) Thyroid function in children with nephrotic syndrome. Mymensingh Med J 20:407\u2013411","journal-title":"Mymensingh Med J"},{"key":"3241_CR190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00856516","volume":"8","author":"S Ito","year":"1994","unstructured":"Ito S, Kano K, Ando T, Ichimura T (1994) Thyroid function in children with nephrotic syndrome. Pediatr Nephrol 8:412\u2013415","journal-title":"Pediatr Nephrol"},{"key":"3241_CR191","unstructured":"[No authors listed] (1986) Demography of dialysis and transplantation in Europe, 1984. Report from the European dialysis and transplant association registry. Nephrol Dial Transplant 1:1\u20138"},{"issue":"Suppl 1","key":"3241_CR192","first-page":"76","volume":"10","author":"S Kuster","year":"1990","unstructured":"Kuster S, Mehls O, Seidel C, Ritz E (1990) Blood pressure in minimal change and other types of nephrotic syndrome. Am J Nephrol 10[Suppl 1]:76\u201380","journal-title":"Am J Nephrol"},{"key":"3241_CR193","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00467-006-0096-4","volume":"21","author":"Z Yi","year":"2006","unstructured":"Yi Z, Li Z, Wu XC, He QN, Dang XQ, He XJ (2006) Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 21:967\u2013972","journal-title":"Pediatr Nephrol"},{"key":"3241_CR194","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00467-003-1314-y","volume":"19","author":"A Bagga","year":"2004","unstructured":"Bagga A, Mudigoudar BD, Hari P, Vasudev V (2004) Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr Nephrol 19:45\u201350","journal-title":"Pediatr Nephrol"},{"key":"3241_CR195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0272-6386(12)80743-8","volume":"21","author":"JJ Olivero","year":"1993","unstructured":"Olivero JJ, Frommer JP, Gonzalez JM (1993) Medical nephrectomy: the last resort for intractable complications of the nephrotic syndrome. Am J Kidney Dis 21:260\u2013263","journal-title":"Am J Kidney Dis"},{"key":"3241_CR196","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fphar.2014.00023","volume":"5","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Mace C, Clement LC, Del Nogal Avila M, Marshall CB (2014) Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease. Front Pharmacol 5:23","journal-title":"Front Pharmacol"},{"key":"3241_CR197","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1681\/ASN.2014030267","volume":"25","author":"C Mace","year":"2014","unstructured":"Mace C, Chugh SS (2014) Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics. J Am Soc Nephrol 25:2393\u20132398","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-015-3241-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3241-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:05:22Z","timestamp":1653509122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-015-3241-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":197,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["3241"],"URL":"https:\/\/doi.org\/10.1007\/s00467-015-3241-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}